News | Brachytherapy Systems | January 16, 2017

Radiation Oncology Centres Launches Australia’s First Electronic Brachytherapy System for Treating Skin Cancer

Esteya system by Elekta providing patients in Australia and New Zealand with a new, gentle treatment option

Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer

January 16, 2017 — On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic brachytherapy to treat her skin cancer lesion, a basal cell carcinoma on her nose. Radiation Oncology Centres (ROC) physicians in Brisbane used their new Esteya electronic brachytherapy system from Elekta to deliver the patient’s first of six non-invasive treatments. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiation therapy directly to the cancer site, reducing radiation to surrounding healthy tissues.

“This first treatment took just 2.5 minutes and the patient tolerated the procedure very well,” said Mike Poulsen, M.D., radiation oncologist at ROC. “She will have just five more therapy visits to complete the treatment, a much quicker course than conventional radiotherapy.”

ROC, part of the Icon Group, is Queensland’s largest provider of radiation therapy services and among Australia’s fastest growing. ROC acquired Esteya in October and the center’s clinicians have been eager to put the system to use in a region with the world’s highest incidence of skin cancer.

“Non-melanoma skin cancers are the most common cancers in Australia and skin cancers account for around 80 percent of newly diagnosed cancers in the country,” Poulsen noted. “About two in three Australians will be diagnosed with skin cancer by the time they are 70, with more than 750,000 people treated for one or more non-melanoma skin cancers in Australia each year. In Queensland alone, over 350,000 non-melanoma skin cancers are treated annually, so the need for skin cancer treatments is great.”

According to Poulsen, Esteya gives suitable patients a good alternative to surgery.

“Our current radiation treatment for skin cancers uses electrons generated from a linear accelerator. While this treatment is very effective for larger skin cancers, it is not ideal for small, superficial lesion,” he explained. “This is where Esteya will be very useful to treat early skin cancers. The advantage of Esteya is that it uses very low energy X-rays, allowing more of the surrounding tissues to avoid unnecessary radiation. The advanced integrated Esteya software also makes treatment delivery extremely safe.”

Esteya treatments are usually given over six to 10 treatment sessions divided over 2-3 times per week, each session lasting just a few minutes. The treatment is typically painless and well tolerated.

In addition to practical reasons such as lesion size, many non-melanoma skin cancer patients may wish to avoid surgery for medical or cosmetic reasons. Esteya provides these patients with an attractive alternative, Poulsen added.

“Ideal candidates for Esteya treatment are older patients, a population in which skin cancers are common,” Poulsen added. “The treatment may also be used for high-risk skin cancers post-surgically to reduce the risk of recurrence locally. This may allow the patient to avoid re-excision of the lesion.”

Another critical advantage of Esteya for the multi-center ROC is the system’s compact size.

“Esteya is extremely compact and portable,” he noted. “This has the potential for the machine to be moved to some of our regional centers, which currently aren’t able to access superficial radiation treatment.”

For more information: www.esteya.com

Related Content

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan. Photo courtesy of Canadian Light Source, University of Saskatchewan

News | Radiation Therapy | May 14, 2020
May 14, 2020 — An innovative radiation treatment t
Medical University of South Carolina researchers have developed and validated prediction tools, known as nomograms, that could be used to help prevent delays in the initiation of radiotherapy after surgery for head and neck cancer

 

Evan Graboyes, M.D., and his team believe their nomogram tools will improve survival rates for head and neck cancer patients. Photo courtesy of MUSC Hollings Cancer Center

 

News | Radiation Oncology | May 14, 2020
May 14, 2020 — More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs i
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...
Figure 1: CT image of lesions in different planes

Figure 1: CT image of lesions in different planes.

Sponsored Content | Case Study | Radiation Oncology | April 30, 2020 | By Christopher Bowen, M.S., DABR
360 Photos | 360 View Photos | April 30, 2020
The company .decimal at ASTRO showed a 3-D prin
Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers

Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers. Image courtesy of Dave Tsai/Los Alamos

News | X-Ray | April 24, 2020
April 24, 2020 — Getting an X-ray at the dentist or